Mohamed Saleh Gomaa/Researchgate.net
Aug 31, 2026, 13:42
Mohamed Saleh Gomaa: Master the Latest in PE Management
Mohamed Saleh Gomaa, Associate Professor of Internal and Critical Care Medicine at Fayoum University, shared a post on LinkedIn:
“Master the latest in pulmonary embolism (PE) management.
This rapid clinical review bridges the gap between hemodynamic theory and bedside practice.
Designed for physicians, residents, and medical students, we break down the physiological impact of acute PE, walk through evidence-based diagnostic algorithms, and integrate the latest 2026 risk stratification guidelines into actionable therapeutic strategies.
What you will learn:
- Pathophysiology and RV strain: Understanding the hemodynamic cascade of acute right ventricular failure.
- Diagnostic pathways: Optimal use of Wells criteria, age-adjusted D-dimer, and CT Pulmonary Angiography (CTPA).
- 2026 risk classification: Navigating the updated criteria for Low, Intermediate-Low (A or B), Intermediate-High (C2/3), and High-Risk (D or E) PE.
- Therapeutic integration: Step-by-step management, from direct oral anticoagulants (DOACs) to systemic thrombolysis, catheter-directed therapies, and ECMO.”
Stay updated with Hemostasis Today.
-
Oct 16, 2026, 17:06Troels Wienecke: Connecting Myeloproliferative Disease and Ischemic Stroke
-
Oct 16, 2026, 17:03Only 5 Days Left to Submit Your Research for EAHAD 2027
-
Oct 16, 2026, 16:48Abdul Rahman: Reticulocyte Count and Bone Marrow Activity
-
Oct 16, 2026, 16:44DOAC Adherence in Stroke Patients With Atrial Fibrillation – International Journal of Stroke
-
Oct 16, 2026, 16:22Shannon Farmer: Driving Patient Blood Management Forward in Australia and New Zealand
-
Oct 16, 2026, 16:01Obi Light Ogbonnia: The Greatest Reward Is Changing Lives, Not Winning Awards
-
Oct 16, 2026, 15:18Carmine Liberatore: Limited Accuracy of VTE Risk Scores in Multiple Myeloma
-
Oct 16, 2026, 14:55Alex Borstein and the Bleeding Phenotype of Hemophilia A Carriers
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification